Children’s Hospital Los Angeles paused the use of Sarepta’s gene therapy for Duchenne muscular dystrophy in the wake of rising safety concerns about liver toxicity, adding to mounting challenges for the drugmaker https://t.co/HBmRIgaNhA ...

Children’s Hospital Los Angeles paused the use of Sarepta’s gene therapy for Duchenne muscular dystrophy in the wake of rising safety concerns about liver toxicity, adding to mounting challenges for the drugmaker https://t.co/WOhmDsWdFS ...